SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DR. BOND who wrote (2926)12/9/1997 8:12:00 PM
From: Steve Childs  Read Replies (2) of 23519
 
Dr. Bond, do you have latest script data? Also, in your post below you said refills are now over 45% of total. It looks to me to be about 31%. (4754 ö 15231)= 31.2%. Question: how many doses are in one script? Also, since Muse has been in the market for around 9 months, shouldn't the refill count be much higher? Or are refill scripts written for many more doses than the new scripts, thereby keeping the percentage low?

HOT OFF THE PRESS...........SCRIPT DATA for week ending Nov. 21..

NEW SCRIPTS 10,477 up 5%
REFILLS 4,754 up 5%
Total 15,231 up 5%

REFILLS ARE NOW 45% of TOTAL! MUSE WORKS AND USERS LOVE IT!!

Go VVUS,

Dr. Bond
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext